
Contents
-
-
-
-
-
-
-
-
-
-
-
Pain management Pain management
-
Pharmacological Interventions Pharmacological Interventions
-
Step one: non-opioid analgesia Step one: non-opioid analgesia
-
Step two: weak opioid Step two: weak opioid
-
Step three: strong opioids Step three: strong opioids
-
Strong opioid titration Strong opioid titration
-
Strong opioids Strong opioids
-
Morphine Morphine
-
Diamorphine (di-acetylmorphine) Diamorphine (di-acetylmorphine)
-
Oxycodone Oxycodone
-
Hydromorphone Hydromorphone
-
Fentanyl Fentanyl
-
Alfentanil Alfentanil
-
Buprenorphine Buprenorphine
-
Methadone Methadone
-
Transdermal buprenorphine Transdermal buprenorphine
-
-
Choice of strong opioid Choice of strong opioid
-
Transdermal opioids Transdermal opioids
-
Opioid toxicity (Fig. ) Opioid toxicity (Fig. )
-
Clinical features of opioid toxicity Clinical features of opioid toxicity
-
Management of opioid toxicity Management of opioid toxicity
-
Opioid switching Opioid switching
-
Adjuvant analgesics Adjuvant analgesics
-
Non-steroidal anti-inflammatory drugs Non-steroidal anti-inflammatory drugs
-
-
Neuropathic pain Neuropathic pain
-
Anticonvulsants Anticonvulsants
-
Antidepressants Antidepressants
-
Ketamine Ketamine
-
Topical lignocaine Topical lignocaine
-
Neuropathic cancer pain—treatment strategy Neuropathic cancer pain—treatment strategy
-
-
Cancer-induced bone pain Cancer-induced bone pain
-
Treatment of CIBP Treatment of CIBP
-
Bisphosphonates Bisphosphonates
-
Anaesthetic interventions Anaesthetic interventions
-
Choice of drug Choice of drug
-
-
-
Non-pharmacological interventions Non-pharmacological interventions
-
Further reading Further reading
-
-
Nausea and vomiting Nausea and vomiting
-
Clinical approach Clinical approach
-
Investigations Investigations
-
Possible causes of nausea and vomiting in cancer Possible causes of nausea and vomiting in cancer
-
Management Management
-
Non-pharmacological measures Non-pharmacological measures
-
First-line antiemetics First-line antiemetics
-
Haloperidol Haloperidol
-
Cyclizine Cyclizine
-
Metoclopramide Metoclopramide
-
5-HT3 antagonists 5-HT3 antagonists
-
-
Second-line antiemetics Second-line antiemetics
-
Levomepromazine Levomepromazine
-
Dexamethasone Dexamethasone
-
-
Further reading Further reading
-
-
Malignant bowel obstruction Malignant bowel obstruction
-
Investigations Investigations
-
Management Management
-
Steroids Steroids
-
Somatostatin analogue (octreotide) Somatostatin analogue (octreotide)
-
Antiemetics Antiemetics
-
Venting gastrostomy Venting gastrostomy
-
Nasogastric intubation Nasogastric intubation
-
-
Malignant bowel obstruction: a strategy Malignant bowel obstruction: a strategy
-
Further reading Further reading
-
-
Constipation Constipation
-
Causes Causes
-
Management Management
-
-
Diarrhoea Diarrhoea
-
Management Management
-
Supportive Supportive
-
Loperamide Loperamide
-
Octreotide Octreotide
-
Antibiotics Antibiotics
-
Opioids Opioids
-
-
-
Hiccups Hiccups
-
Common causes Common causes
-
Management Management
-
Gastric distension and GORD Gastric distension and GORD
-
Smooth muscle relaxants Smooth muscle relaxants
-
Central hiccup reflex suppression Central hiccup reflex suppression
-
-
-
Depression Depression
-
Diagnosis Diagnosis
-
Principles of management Principles of management
-
Drug treatments Drug treatments
-
Citalopram Citalopram
-
Mirtazapine Mirtazapine
-
Venlafaxine Venlafaxine
-
Psychostimulants, e.g. methylphenidate Psychostimulants, e.g. methylphenidate
-
-
Further reading Further reading
-
-
Delirium Delirium
-
Causes of delirium in cancer patients Causes of delirium in cancer patients
-
Diagnosis of delirium Diagnosis of delirium
-
Informal methods Informal methods
-
Formal methods Formal methods
-
-
Treatment of delirium Treatment of delirium
-
Further reading Further reading
-
-
Oral care Oral care
-
Xerostomia Xerostomia
-
Treatment Treatment
-
-
Oral infections Oral infections
-
General principles of management General principles of management
-
-
-
Cancer-related fatigue Cancer-related fatigue
-
Epidemiology Epidemiology
-
Causes Causes
-
Treatment Treatment
-
Further reading Further reading
-
-
Cancer cachexia Cancer cachexia
-
Epidemiology Epidemiology
-
Pathophysiology Pathophysiology
-
Treatments Treatments
-
Further reading Further reading
-
-
Breathlessness Breathlessness
-
Epidemiology Epidemiology
-
Pathophysiology Pathophysiology
-
Common causes Common causes
-
Management Management
-
General principles General principles
-
Correct reversible causes Correct reversible causes
-
Cancer specific treatment Cancer specific treatment
-
Drainage of effusions Drainage of effusions
-
Oxygen therapy (Booth et al. ) Oxygen therapy (Booth et al. )
-
Opioids Opioids
-
Benzodiazepines Benzodiazepines
-
-
-
Further reading Further reading
-
-
Cough Cough
-
Management Management
-
General principles General principles
-
Expectorants Expectorants
-
Cough suppressants (antitussives) Cough suppressants (antitussives)
-
-
-
Haemoptysis Haemoptysis
-
Symptom clusters Symptom clusters
-
Further reading Further reading
-
-
End of life care End of life care
-
Recognition of end of life Recognition of end of life
-
Signs of dying Signs of dying
-
General principles of end of life care General principles of end of life care
-
Principles of drug use in end of life care Principles of drug use in end of life care
-
Specific symptom control Specific symptom control
-
Pain Pain
-
Dyspnoea Dyspnoea
-
Anxiety/restlessness Anxiety/restlessness
-
Delirium/acute-confusional state (Table ) Delirium/acute-confusional state (Table )
-
Respiratory secretions Respiratory secretions
-
Mouth care Mouth care
-
Fluids and parenteral nutrition Fluids and parenteral nutrition
-
-
Psychological aspects of end of life care Psychological aspects of end of life care
-
Dignity therapy Dignity therapy
-
How long? How long?
-
The bitter or angry patient The bitter or angry patient
-
Post-death care Post-death care
-
Conclusion Conclusion
-
Further reading Further reading
-
Internet resource Internet resource
-
-
-
-
-
-
-
Cite
Extract
Pain management
Pharmacological Interventions
In general, cancer pain management should be focused on the three-step WHO analgesic ladder for cancer pain relief (Ventafridda et al. 1997) (Fig. 7.1.1) This strategy should, however, be integrated with other methods, as appropriate, of cancer pain control. This includes tumoricidal therapy, radiotherapy, palliative surgery, physiotherapy, occupational therapy, anaesthetic interventions, psychosocial care, and any other care which adds to pain relief. It can be more appropriate with some patients to miss step two of the ladder and simply prescribe low-dose step three (strong opioid) which can mean fewer drug changes. In specialist units, the WHO ladder will relieve up to 80% of cancer pain.
...
Step one: non-opioid analgesia
The most common non-opioid analgesic used is paracetamol, usually prescribed 1g four times daily. The side effects of paracetamol are minimal and it is generally effective in mild pain. As paracetamol works differently from opioids, it is usual to continue it even on the second and third steps of the analgesic ladder. Non-steroidal anti-inflammatory drugs (NSAIDs) are an alternative or addition to paracetamol at each step.
Sign in
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
- Add your ORCID iD
Purchase
Our books are available by subscription or purchase to libraries and institutions.
Purchasing informationMonth: | Total Views: |
---|---|
October 2022 | 1 |
June 2024 | 1 |
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.